Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2025.1730898 Correction Correction: Genetic profile of a large Spanish cohort with hypercalcemia García-CastañoAlejandro 1 † Validation Conceptualization Writing – review & editing Methodology Writing – original draft Investigation Formal analysis Funding acquisition MadariagaLeire 2 † Writing – review & editing Writing – original draft Investigation Visualization Funding acquisition Conceptualization Gómez-CondeSara 3 Formal analysis Writing – original draft Methodology Investigation Validation Writing – review & editing GonzálezPedro 4 Resources Visualization Investigation Validation Writing – review & editing GrauGema 5 Resources Visualization Validation Investigation Writing – review & editing RicaItxaso 6 Visualization Validation Resources Writing – review & editing Investigation de NanclaresGustavo Pérez 1 Investigation Data curation Methodology Writing – review & editing Formal analysis De la HozAna Belén 1 Writing – review & editing Methodology AguayoAníbal 1 Writing – review & editing Investigation Resources Validation MartínezRosa 1 Visualization Investigation Validation Writing – review & editing UrrutiaInés 1 Validation Visualization Writing – review & editing Investigation GaztambideSonia 7 Conceptualization Writing – review & editing Validation Data curation Visualization Writing – original draft Calcium Phosphorus Metabolism Molecular Biology Group Writing – review & editing Writing – original draft Conceptualization Funding acquisition Resources Data curation Validation Investigation CastañoLuis 3 * Writing – review & editing Writing – original draft Conceptualization Funding acquisition Resources Data curation Validation Investigation Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain Pediatric Nephrology Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain Endocrinology and Nutrition Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, EndoERN, Barakaldo, Bizkaia, Spain Pediatric Endocrinology Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, EndoERN, Barakaldo, Bizkaia, Spain Pediatric Endocrinology Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain Endocrinology and Nutrition Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain Correspondence: Luis Castaño, luisantonio.castanogonzalez@osakidetza.eus

These authors have contributed equally to this work

 14 11 2025 2025 16 1730898 23 10 2025 24 10 2025 Copyright © 2025 García-Castaño, Madariaga, Gómez-Conde, González, Grau, Rica, de Nanclares, De la Hoz, Aguayo, Martínez, Urrutia, Gaztambide, Calcium Phosphorus Metabolism Molecular Biology Group and Castaño. 2025 García-Castaño, Madariaga, Gómez-Conde, González, Grau, Rica, de Nanclares, De la Hoz, Aguayo, Martínez, Urrutia, Gaztambide, Calcium Phosphorus Metabolism Molecular Biology Group and Castaño https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Genetic profile of a large Spanish cohort with hypercalcemia By García-Castaño A, Madariaga L, Gómez-Conde S, González P, Grau G, Rica I, de Nanclares GP, De la Hoz AB, Aguayo A, Martínez R, Urrutia I, Gaztambide S, Calcium Phosphorus Metabolism Molecular Biology Group and Castaño L (2024) Front. Endocrinol. 15:1297614. doi: 10.3389/fendo.2024.1297614 NGS calcium hypercalcemia hypocalciuria hyperparathyroidism section-at-acceptance Molecular and Structural Endocrinology

An incorrect Funding statement was provided. The Funding statement for the Institute of Health Carlos III was displayed as “Institute of Health Carlos III (PI21/01419)” The correct Funding statement reads: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Project PI21/01419, funded by the Instituto de Salud Carlos III and co-funded by European Union (ERDF “A way to make Europe”); the Department of Health (2019111052); and the Department of Education (IT-1281-19) of the Basque Government. This work is generated within the Endocrine European Reference Network (Project ID number of Endo-ERN: 739527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland